Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT00062166
Eligibility Criteria:
* INCLUSION CRITERIA:
Patients who have been diagnosed with Von Hippel Lindau (VHL) using the following criteria: either germ line analysis (12) or clinical criteria and a family history (8, 12) and who have at least 1 pancreatic manifestation of VHL as documented on any non-invasive imaging study. These manifestations include:
1. Pancreatic cyst(s).
2. Solid lesions suspicious for microcystic adenoma(s).
3. Solid enhancing lesions suspicious for primitive neuroectodermal tumor (PNET)(s).
4. Any other solid lesion(s) of the pancreas.
Age greater than or equal to 12 years of age.
Patients must be willing to return to National Institutes of Health (NIH) for follow-up.
Patients/parent must be able to sign an informed consent.
EXCLUSION CRITERIA:
Patients unwilling to undergo serial non-invasive imaging.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
12 Years
Maximum Age:
80 Years
Study:
NCT00062166
Study Brief:
Protocol Section:
NCT00062166